Delhi HC Restrains BECO’s Comparative Ad Campaign Against HUL

Key Facts

1. BECO launched a campaign across social media, hoardings, and website listings explicitly targeting HUL’s “Vim” and “Surf Excel” products.
2. BECO highlighted presence of specific chemical ingredients (such as LAS and BIT) in HUL’s products, alleging they “can cause skin irritation,” and urged consumers to “SWITCH TO BECO”.
3. BECO argued that its ingredient-level claims were truthful, backed by accredited lab reports, and aimed at educating Indian consumers.

Court’s Findings

4. Truth cannot be evaluated by isolating technical facts. Juxtaposing chemical facts with health warnings and a direct push to “SWITCH TO BECO” creates a overall misleading message that a competitor’s safe product is hazardous.
5. Unlike classic defamation, a defendant in a commercial disparagement suit cannot escape an injunction simply by claiming they will prove “truth” at trial. Unless the defense demonstrates prima facie credibility, courts will protect the competitor’s commercial goodwill during the trial. Court held that “permissible comparative advertising is subject to the caveat and qualification that it must not be based on statements that are not truthful and/or that misrepresent a state of affairs and/or that are deceptive/misleading – in their overall effect and impact.”
6. Advertisers cannot hide denigration or unfair comparison behind scientific jargon or selective ingredient disclosures.

Practical Takeaways for Legal and Marketing Teams

7. Review comparative ads from the perspective of an average consumer. A campaign can be legally disparaging if the overall message scares consumers, even if individual chemical claims are technically accurate.
8. Highlighting common industry ingredients as dangerous toxins to promote your own product crosses the line into disparagement.
9. Comparative advertising remains permissible, provided it compares verifiable features without denigrating competitor brands.